Lack of Bax expression is associated with irinotecan-based treatment activity in advanced colorectal cancer patients

被引：0
|
作者：
F. Pietrantonio
P. Biondani
M. Milione
F. Melotti
G. Bertarelli
F. Perrone
F. de Braud
L. Mariani
G. Fanetti
D. Cortinovis
M. Di Bartolomeo
机构：
[1] Fondazione IRCCS Istituto Nazionale Dei Tumori,Medical Oncology Unit 1, Medical Oncology Department
[2] Fondazione IRCCS Istituto Nazionale Tumori,Pathology Department
[3] Fondazione IRCCS Istituto Nazionale Tumori,Statistics and Biometry Unit
[4] A.O. San Gerardo,Medical Oncology Unit
来源：
Clinical and Translational Oncology | 2013年 / 15卷
关键词：
Bax; Colorectal cancer; Biomarkers; Chemotherapy; Irinotecan;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：582 / 586
页数：4
相关论文
共 50 条
  • [1] Lack of Bax expression is associated with irinotecan-based treatment activity in advanced colorectal cancer patients
    Pietrantonio, F.
    Biondani, P.
    Milione, M.
    Melotti, F.
    Bertarelli, G.
    Perrone, F.
    de Braud, F.
    Mariani, L.
    Fanetti, G.
    Cortinovis, D.
    Di Bartolomeo, M.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2013, 15 (07): : 582 - 586
  • [2] Antibiotics Improve the Treatment Efficacy of Oxaliplatin-Based but Not Irinotecan-Based Therapy in Advanced Colorectal Cancer Patients
    Imai, Hiroo
    Saijo, Ken
    Komine, Keigo
    Yoshida, Yuya
    Sasaki, Keiju
    Suzuki, Asako
    Ouchi, Kota
    Takahashi, Masahiro
    Takahashi, Shin
    Shirota, Hidekazu
    Takahashi, Masanobu
    Ishioka, Chikashi
    JOURNAL OF ONCOLOGY, 2020, 2020
  • [3] Clinical Pharmacokinetics of Irinotecan-Based Chemotherapy in Colorectal Cancer Patients
    Di Paolo, Antonello
    Bocci, Guido
    Danesi, Romano
    Del Tacca, Mario
    CURRENT CLINICAL PHARMACOLOGY, 2006, 1 (03): : 311 - 323
  • [4] Aprataxin Tumor Levels Predict Response of Colorectal Cancer Patients to Irinotecan-based Treatment
    Dopeso, Higinio
    Mateo-Lozano, Silvia
    Elez, Elena
    Landolfi, Stefania
    Ramos Pascual, Francisco Javier
    Hernandez-Losa, Javier
    Mazzolini, Rocco
    Rodrigues, Paulo
    Bazzocco, Sarah
    Josep Carreras, Maria
    Espin, Eloy
    Armengol, Manel
    Wilson, Andrew J.
    Mariadason, John M.
    Ramon y Cajal, Santiago
    Tabernero, Josep
    Schwartz, Simo, Jr.
    Arango, Diego
    CLINICAL CANCER RESEARCH, 2010, 16 (08) : 2375 - 2382
  • [5] Bevacizumab plus Irinotecan-Based Regimens in the Treatment of Metastatic Colorectal Cancer
    Heinemann, Volker
    Hoff, Paulo M.
    ONCOLOGY, 2010, 79 (1-2) : 118 - 128
  • [6] Advanced colorectal cancer subtypes (aCRCS) help select oxaliplatin-based or irinotecan-based therapy for colorectal cancer
    Takahashi, Shin
    Sakamoto, Yasuhiro
    Denda, Tadamichi
    Takashima, Atsuo
    Komatsu, Yoshito
    Nakamura, Masato
    Ohori, Hisatsugu
    Yamaguchi, Tatsuro
    Kobayashi, Yoshimitsu
    Baba, Hideo
    Kotake, Masanori
    Amagai, Kenji
    Kondo, Hitoshi
    Shimada, Ken
    Sato, Atsushi
    Yuki, Satoshi
    Okita, Akira
    Ouchi, Kota
    Komine, Keigo
    Watanabe, Mika
    Morita, Satoshi
    Ishioka, Chikashi
    CANCER SCIENCE, 2021, 112 (04) : 1567 - 1578
  • [7] UGT1A1 gene polymorphism is associated with toxicity and clinical efficacy of irinotecan-based chemotherapy in patients with advanced colorectal cancer
    Xu, Chunlei
    Tang, Xushan
    Qu, Yanli
    Keyoumu, Saifuding
    Zhou, Ning
    Tang, Yong
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2016, 78 (01) : 119 - 130
  • [8] UGT1A1 gene polymorphism is associated with toxicity and clinical efficacy of irinotecan-based chemotherapy in patients with advanced colorectal cancer
    Chunlei Xu
    Xushan Tang
    Yanli Qu
    Saifuding Keyoumu
    Ning Zhou
    Yong Tang
    Cancer Chemotherapy and Pharmacology, 2016, 78 : 119 - 130
  • [9] Irinotecan in the treatment of elderly patients with advanced colorectal cancer
    Sastre, Javier
    Puente, Javier
    Garcia-Saenz, Jose A.
    Diaz-Rubio, Eduardo
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2008, 68 (03) : 250 - 255
  • [10] Isolated hepatic perfusion for the treatment of patients with colorectal cancer liver metastases after irinotecan-based therapy
    Alexander, HR
    Libutti, SK
    Pingpank, JF
    Bartlett, DL
    Helsabeck, C
    Beresneva, T
    ANNALS OF SURGICAL ONCOLOGY, 2005, 12 (02) : 138 - 144
12345